Clinical evaluation of a new acrylic microincision intraocular lens

Session Details

Session Title: IOL Technology / Accommodative IOLs etc.

Session Date/Time: Saturday 13/09/2014 | 16:00-18:00

Paper Time: 17:42

Venue: Boulevard A

First Author: : B.Toygar TURKEY

Co Author(s): :    O. Yabas Kiziloglu   O. Toygar   A. Hacimustafaoglu   K. Keskinbora     

Abstract Details

Purpose:

To assess the safety and efficacy of a new acrylic intraocular lens (IOL) for microincision cataract surgery (MICS). The IOL comprises an acrylic material with a 22% water content, 4 angulated haptics and an aberration-free aspheric optic.

Setting:

Bahçesehir University Faculty of Medical , Medical Park Hospital Göztepe, Istanbul, Turkey

Methods:

A single centre, single surgeon study where 44 eyes (27 patients) were implanted with the MICS IOL (Incise; B+L) following phacoemulsification (Stellaris; B+L). The Viscoject 1.5 inserter was used for IOL implantation. Visual acuity, refraction, average phaco time (APT) and effective phaco time (EPT) were assessed.

Results:

Twenty seven subjects (19 Female; 8 Male) had a mean patient age of 79 ±+7.96 years (range: 57 to 84). Lens power implanted ranged from 18D to 23.5D and incision size ranged from 1.3 to 2.4 mm. A wound-assist implantation technique was used for the 1.3mm incisions. Mean pre-operative corrected visual acuity (CDVA) was 0.7 logMAR (20/100 Snellen). Intra-operatively, median APT was 25.4s, ranging from 5.9s in cataract grade 1+ to 146s in cataract grade 5+. Median EPT was 4.7s (range: 0.6 to 30.5s). At one week post-op (32 eyes), mean CDVA was 0.1±0.06 logMAR (20/25 Snellen) with an average gain of 4 lines. Mean refractive spherical equivalent (MRSE) was -0.30±0.9D. At one month post-op (16 eyes), median CDVA was 0.0 logMAR (20/20) (range: 0.0 to 0.7; one subject with age-related macular degeneration). Median MRSE was -0.2D. Further longer term follow-up data will be presented.

Conclusions:

Early experience finds the Incise IOL is safe and effective, providing a good improvement in visual acuity.

Financial Interest:

One or more of the authors... receives consulting fees, retainer, or contract payments from a competing company, One or more of the authors... travel has been funded, fully or partially, by a company producing, developing or supplying the product or procedure presented